Literature DB >> 28378289

Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.

G Bardai1, L M Ward2, P Trejo1, P Moffatt1, F H Glorieux1, F Rauch3.   

Abstract

In 26 of 94 individuals (28%) below 21 years of age who had a significant fracture history but did not have extraskeletal features of osteogenesis imperfecta (OI), we detected disease-causing mutations in OI-associated genes.
INTRODUCTION: In children who have mild bone fragility but do not have extraskeletal features of OI, it can be difficult to establish a diagnosis on clinical grounds. Here, we assessed the diagnostic yield of genetic testing in this context, by sequencing a panel of genes that are associated with OI.
METHODS: DNA sequence analysis was performed on 94 individuals below 21 years of age who had a significant fracture history but had white sclera and no signs of dentinogenesis imperfecta.
RESULTS: Disease-causing variants were detected in 28% of individuals and affected 5 different genes. Twelve individuals had mutations in COL1A1 or COL1A2, 8 in LRP5, 4 in BMP1, and 2 in PLS3.
CONCLUSIONS: DNA sequence analysis of currently known OI-associated genes identified disease-causing variants in more than a quarter of individuals with a significant fracture history but without extraskeletal manifestations of OI.

Entities:  

Keywords:  Children; Fractures; Mutations; Next-generation sequencing; Osteogenesis imperfecta

Mesh:

Substances:

Year:  2017        PMID: 28378289     DOI: 10.1007/s00198-017-4031-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.

Authors:  F Rauch; R Travers; A M Parfitt; F H Glorieux
Journal:  Bone       Date:  2000-06       Impact factor: 4.398

Review 2.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

3.  Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.

Authors:  Somayyeh Fahiminiya; Jacek Majewski; Hadil Al-Jallad; Pierre Moffatt; John Mort; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Frank Rauch
Journal:  J Bone Miner Res       Date:  2014-08       Impact factor: 6.741

4.  Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α.

Authors:  G Brunetti; F Papadia; A Tummolo; R Fischetto; F Nicastro; L Piacente; A Ventura; G Mori; A Oranger; I Gigante; S Colucci; M Ciccarelli; M Grano; L Cavallo; M Delvecchio; M F Faienza
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

5.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

Review 6.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

7.  Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I.

Authors:  Frank Rauch; Liljana Lalic; Peter Roughley; Francis H Glorieux
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

Review 8.  Osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

9.  Low-density lipoprotein receptor-related protein 5 (LRP5) variation in fracture prone children.

Authors:  Anne Saarinen; Mervi K Mäyränpää; Anna-Elina Lehesjoki; Outi Mäkitie
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

10.  Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.

Authors:  Johanna Korvala; Harald Jüppner; Outi Mäkitie; Etienne Sochett; Dirk Schnabel; Stefano Mora; Cynthia F Bartels; Matthew L Warman; Donald Deraska; William G Cole; Heini Hartikka; Leena Ala-Kokko; Minna Männikkö
Journal:  BMC Med Genet       Date:  2012-04-10       Impact factor: 2.103

View more
  10 in total

1.  Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.

Authors:  Y Liu; D Ma; F Lv; X Xu; J Wang; W Xia; Y Jiang; O Wang; X Xing; W Yu; J Wang; J Sun; L Song; Y Zhu; H Yang; J Wang; M Li
Journal:  Osteoporos Int       Date:  2017-07-19       Impact factor: 4.507

2.  A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.

Authors:  Leanne M Ward; David R Weber; Craig F Munns; Wolfgang Högler; Babette S Zemel
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 3.  Plastin 3 in health and disease: a matter of balance.

Authors:  Lisa Wolff; Eike A Strathmann; Ilka Müller; Daniela Mählich; Charlotte Veltman; Anja Niehoff; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2021-05-23       Impact factor: 9.261

Review 4.  Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research.

Authors:  Josephine T Tauer; Marie-Eve Robinson; Frank Rauch
Journal:  JBMR Plus       Date:  2019-02-20

5.  A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta.

Authors:  Jing Hu; Lu-Jiao Li; Wen-Bin Zheng; Di-Chen Zhao; Ou Wang; Yan Jiang; Xiao-Ping Xing; Mei Li; Weibo Xia
Journal:  Mol Genet Genomic Med       Date:  2020-11-09       Impact factor: 2.183

6.  Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the WNT1 gene.

Authors:  Maria Cristina Campopiano; Antonella Fogli; Angela Michelucci; Laura Mazoni; Antonella Longo; Simona Borsari; Elena Pardi; Elena Benelli; Chiara Sardella; Laura Pierotti; Elisa Dinoi; Claudio Marcocci; Filomena Cetani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

7.  Diagnostic utility of next-generation sequence genetic panel testing in children presenting with a clinically significant fracture history.

Authors:  Jennifer Harrington; Abdulmajeed AlSubaihin; Lucie Dupuis; Peter Kannu; Roberto Mendoza-Londono; Andrew Howard
Journal:  Arch Osteoporos       Date:  2021-06-05       Impact factor: 2.617

8.  Population study evaluating fracture risk among patients with chronic osteomyelitis.

Authors:  Chyi Lo; Fung-Chang Sung; Chih-Hsin Mou; Tzu-Chieh Lin; Chun-Huang Tseng; Ya-Ling Tzeng
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

Review 9.  Genetic approaches to metabolic bone diseases.

Authors:  Fadil M Hannan; Paul J Newey; Michael P Whyte; Rajesh V Thakker
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

10.  Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.

Authors:  Ralf Oheim; Elena Tsourdi; Lothar Seefried; Gisela Beller; Max Schubach; Eik Vettorazzi; Julian Stürznickel; Tim Rolvien; Nadja Ehmke; Alena Delsmann; Franca Genest; Ulrike Krüger; Tomasz Zemojtel; Florian Barvencik; Thorsten Schinke; Franz Jakob; Lorenz C Hofbauer; Stefan Mundlos; Uwe Kornak
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.